Researchers estimated dietary polyphenol intake in healthy adults and investigated its associations with gastrointestinal and systemic inflammation markers.
Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC
The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or